References
- Taylor H. R., Johnson S. L., Prendergast R. A., Schachter J., Dawson C. R., Silverstein A. M. An animal model of trachoma. II. The importance of repeated reinfection. Invest. Ophthalmol. Vis. Sci. 1982; 23: 507–517
- Taylor H. R., Prendergast R. A., Dawson C. R., Schachter J., Silverstein A. M. An animal model for cicatrizing trachoma. Invest. Ophthalmol. Vis. Sci. 1981; 21: 422–433
- Kunimoto D., Brunham R. C. Human immune response and Chlamydia trachomatis infection. Rev. Infect. Dis. 1985; 7: 665–669
- Whittum-Hudson J. A., Taylor H. R., Farazdaghi M., Prendergast R. A. Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. Invest. Ophthalmol. Vis. Sci. 1986; 27: 64–69
- Young E., Taylor H. R. Immune mechanisms in chlamydial eye infections: Cellular immune responses in chronic and acute disease. J. Infect. Dis. 1984; 150: 745–751
- Hess A. D., Tutschka P. J., Santos G. W. Effect of cyclosporine on the induction of cytotoxic T lymphocytes: Role of interleukin-1 and interleukin-2. Cyclosporine biological activity and clinical applications, B. D. Kahan. Grune & Stratton, Inc., Orlando 1984; Volume I: 32–42
- Taylor H. R., Young E., MacDonald A. B., Schachter J., Prendergast R. A. Oral immunization against chlamydial eye infection. Invest. Ophthalmol. Vis. Sci.
- Taylor H. R., Johnson S. L., Agarwala N. The detection of Chlamydia trachomatis eye infection in conjunctival smears and in tissue culture with a fluorescein conjugated monoclonal antibody. J. Clin. Microbiol. 1984; 20: 391–395
- Wang S. P., Grayston J. T. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am. J. Ophthalmol. 1970; 70: 367–374
- Young E., Taylor H. R. Immune mechanisms in chlamydial eye infection: Development of T suppressor cells. Invest. Ophthalmol. Vis. Sci. 1986; 27: 615–619
- Donnelly J. J., Taylor H. R., Young E. M., Khatami M., Lok J. B., Rockey J. H. Experimental ocular onchocerciasis in cynomolgous monkeys. Invest. Ophthalmol. Vis. Sci. 1986; 27: 492–499
- Garnett N. L., Taylor H. R., Hoffman G. J., Heberling R. L., Ambinder R. F., Huber A. C., Valentine B. A. Malignant lymphoma in nontransplanted cynomolgus monkeys receiving cyclosporine. Cyclosporine biological activity and clinical applications, B. D. Kahan. Grune & Stratton, Inc., Orlando 1984; Volume I: 592–596
- Klaus G. G.B., Kunkl A. Dissociation of T helper-cell function and helper-cell priming by cyclosporine. Cyclosporine biological activity and clinical applications, B. D. Kahan. Grune & Stratton, Inc., Orlando, Volume I: 105–106
- Klaus G. G.B., Chisholm P. M. Does cyclosporine act in vivo as it does in vitro?. Immunol. Today 1986; 7: 101–103
- Borel J. F. Transplantation and clinical immunology, J. L. Touraine, J. Traeger, H. Betuel. Excerpta Medica, Amsterdam 1981; Vol. XXII: 3
- Underdown B. J., Schiff J. M. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annual Review of Immunology, W. E. Paul. Annual Reviews, Inc., Palo Alto 1986; Vol. 4: 389–417
- Ogra P. L. Local immune responses. Br. Med. Bull. 1985; 41: 28